✦ LIBER ✦

Correction to Selective Class I Phosphoinositide 3-Kinase Inhibitors: Optimization of a Series of Pyridyltriazines Leading to the Identification of a Clinical Candidate, AMG 511

✍ Scribed by Norman, Mark H.; Andrews, Kristin L.; Bo, Yunxin Y.; Booker, Shon K.; Caenepeel, Sean; Cee, Victor J.; D’Angelo, Noel D.; Freeman, Daniel J.; Herberich, Bradley J.; Hong, Fang-Tsao; Jackson, Claire L. M.; Jiang, Jian; Lanman, Brian A.; Liu, Longbin; McCarter, John D.; Mullady, Erin L.; Nishimura, Nobuko; Pettus, Liping H.; Reed, Anthony B.; Miguel, Tisha San; Smith, Adrian L.; Stec, Markian M.; Tadesse, Seifu; Tasker, Andrew; Aidasani, Divesh; Zhu, Xiaochun; Subramanian, Raju; Tamayo, Nuria A.; Wang, Ling; Whittington, Douglas A.; Wu, Bin; Wu, Tian; Wurz, Ryan P.; Yang, Kevin; Zalameda, Leeanne; Zhang, Nancy; Hughes, Paul E.

Book ID: 126422634
Publisher: American Chemical Society
Year: 2012
Tongue: English
Weight: 112 KB
Volume: 55
Category: Article
ISSN: 0022-2623
DOI: 10.1021/jm301439j

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Selective Cannabinoid Receptor Type 2 (C

Selective Cannabinoid Receptor Type 2 (CB2) Agonists: Optimization of a Series of Purines Leading to the Identification of a Clinical Candidate for the Treatment of Osteoarthritic Pain

✍ Hollinshead, Sean P.; Tidwell, Michael W.; Palmer, John; Guidetti, Rossella; San 📂 Article 📅 2013 🏛 American Chemical Society 🌐 English ⚖ 739 KB

Correction to Discovery of a Novel Class

Correction to Discovery of a Novel Class of Exquisitely Selective Mesenchymal-Epithelial Transition Factor (c-MET) Protein Kinase Inhibitors and Identification of the Clinical Candidate 2-(4-(1-(Quinolin-6-ylmethyl)-1 H -[1,2,3]triazolo[4,5- b ]pyrazin-6-yl)-1 H -pyrazol-1-yl)ethanol (PF-04217903) for the Treatment of Cancer

✍ Cui, J. Jean; McTigue, Michele; Nambu, Mitchell; Tran-Dubé, Michelle; Pairish, M 📂 Article 📅 2012 🏛 American Chemical Society 🌐 English ⚖ 124 KB